Vaughan Nelson Investment Management L.P. raised its stake in shares of Cushman & Wakefield plc (NYSE:CWK - Free Report) by 9.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,474,380 shares of the company's stock after acquiring an additional 1,094,260 shares during the quarter. Cushman & Wakefield makes up 1.5% of Vaughan Nelson Investment Management L.P.'s portfolio, making the stock its 16th biggest position. Vaughan Nelson Investment Management L.P. owned 5.44% of Cushman & Wakefield worth $163,164,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company raised its position in shares of Cushman & Wakefield by 43.1% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 81,974 shares of the company's stock valued at $853,000 after acquiring an additional 24,697 shares in the last quarter. Truist Financial Corp bought a new stake in Cushman & Wakefield during the second quarter valued at $221,000. Handelsbanken Fonder AB raised its holdings in shares of Cushman & Wakefield by 6.5% during the third quarter. Handelsbanken Fonder AB now owns 24,500 shares of the company's stock worth $334,000 after purchasing an additional 1,500 shares during the period. GAMMA Investing LLC lifted its position in shares of Cushman & Wakefield by 45.8% in the 3rd quarter. GAMMA Investing LLC now owns 5,186 shares of the company's stock worth $71,000 after buying an additional 1,629 shares during the last quarter. Finally, CWM LLC boosted its holdings in shares of Cushman & Wakefield by 67.6% in the 3rd quarter. CWM LLC now owns 9,167 shares of the company's stock valued at $125,000 after buying an additional 3,699 shares during the period. 95.56% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research firms recently weighed in on CWK. The Goldman Sachs Group initiated coverage on shares of Cushman & Wakefield in a research note on Friday, December 6th. They set a "sell" rating and a $15.00 price objective on the stock. JPMorgan Chase & Co. raised their price target on Cushman & Wakefield from $14.00 to $17.00 and gave the stock a "neutral" rating in a report on Monday, December 16th. Finally, Jefferies Financial Group downgraded Cushman & Wakefield from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $18.00 to $14.00 in a research note on Thursday, January 2nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $15.50.
Get Our Latest Stock Report on Cushman & Wakefield
Cushman & Wakefield Stock Performance
CWK stock traded down $0.32 during trading on Wednesday, reaching $12.77. 1,197,968 shares of the company's stock were exchanged, compared to its average volume of 1,478,602. Cushman & Wakefield plc has a 1-year low of $9.24 and a 1-year high of $16.11. The firm has a market cap of $2.93 billion, a PE ratio of 34.51 and a beta of 1.34. The company's fifty day moving average price is $13.45 and its 200-day moving average price is $13.41. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.76.
About Cushman & Wakefield
(
Free Report)
Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America.
Recommended Stories

Before you consider Cushman & Wakefield, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cushman & Wakefield wasn't on the list.
While Cushman & Wakefield currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.